Dear Reader,

As we approach the end of 2016, and publish our final issue of Pediatric Drugs for the year, the editors and production staff at Adis wish to reflect on another successful year for the journal and for others in the Adis Premier journals portfolio, and to thank all who have contributed to Pediatric Drugs over the past 12 months.

Mid-2016 saw the release of the ISI Journal Citation Reports and the latest journal impact factors. The impact factor for Pediatric Drugs continues its upwards momentum, with a 5% increase to 2.077. The majority of our other journals also saw a rise in impact factor against the previous year. Most notably, five of our journals saw an increase of over 10% in impact factor–The Patient (17%), Clinical Drug Investigation (16%), the American Journal of Clinical Dermatology (13%), Drug Safety (13.5%), and Drugs (12.5%).

As of October 2016, Pediatric Drugs’ top 10 downloaded articles from SpringerLink this year were:

Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities. Bronckers IM, Paller AS, van Geel MJ, van de Kerkhof PC, Seyger MM. Pediatr Drugs. 2015;17(5):373–84.

The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts. Cruchet S, Furnes R, Maruy A, Hebel E, Palacios J, Medina F, Ramirez N, Orsi M, Rondon L, Sdepanian V, Xóchihua L, Ybarra M, Zablah RA. Pediatr Drugs. 2015;17(3):199–216.

Management of Functional Constipation in Children: Therapy in Practice. Koppen IJ, Lammers LA, Benninga MA, Tabbers MM. Pediatr Drugs. 2015;17(5):349–60.

Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine. Maagdenberg H, Vijverberg SJ, Bierings MB, Carleton BC, Arets HG, de Boer A, Maitland-van der Zee AH. Pediatr Drugs. 2016;18(4):251–60.

A Qualitative Study into Dependent Relationships and Voluntary Informed Consent for Research in Pediatric Oncology. Dekking SA, van der Graaf R, Schouten-van Meeteren AY, Kars MC, van Delden JJ. Pediatr Drugs. 2016;18(2):145–56.

Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy. Rivera-Valentin RK, Zhu L, Hughes DP. Pediatr Drugs. 2015;17(4):257–71.

Pain in Intellectually Disabled Children: Towards Evidence-Based Pharmacotherapy? Valkenburg AJ, de Leeuw TG, van Dijk M, Tibboel D. Pediatr Drugs. 2015;17(5):339–48.

Omalizumab in children. Licari A, Marseglia A, Caimmi S, Castagnoli R, Foiadelli T, Barberi S, Marseglia GL. Pediatr Drugs. 2014;16(6):491–502.

Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherence. Braamskamp MJ, Kusters DM, Avis HJ, Smets EM, Wijburg FA, Kastelein JJ, Wiegman A, Hutten BA. Pediatr Drugs. 2015;17(2):159–66.

Clinical features and pharmacotherapy of childhood monoamine neurotransmitter disorders. Ng J, Heales SJ, Kurian MA. Pediatr Drugs. 2014;16(4):275–91.

We offer our sincere thanks to all authors who have contributed articles to Pediatric Drugs over the course of 2016. Their skill and dedication are critical to the continued publication of the journal.

The quality of published articles is, similarly, testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal’s content is held to the highest possible standard. We would like to thank the following individuals who acted as reviewers for articles published in Pediatric Drugs in 2016:

Ishaq Abu-Arafeh, UK

Arash Afshari, Denmark

Karel Allegaert, Belgium

Nicole Almenrader, Italy

Anup Amatya, USA

Richard E. Appleton, UK

Antonio C. Arrieta, USA

Keith J. August, USA

Thomas M. Austin, USA

Tadej Avcin, Slovenia

Craig Bailey, UK

Alexandre Belot, France

John W. Berkenbosch, USA

Frank M.C. Besag, UK

Jeffrey Blumer, USA

Jacob Brogren, Sweden

Francesco Paolo Cantatore, Italy

Joseph B. Cantey, USA

Alberto Chiarugi, Italy

Catherine Chiron, France

Laurent Chouchana, France

Helena L. Coelho, Brazil

Aaron Conway, Australia

James R. Couch Jr, USA

Joseph P. Cravero, USA

Stacy Croteau, USA

Salvatore Cucchiara, Italy

Lydia D’Agostino, USA

Souhayl Dahmani, France

Tiphaine A. de Beaumais, France

Lissy de Ridder, the Netherlands

Stefan De Smedt, Belgium

Alcidesio de Souza Junior, Brazil

Bart De Spiegeleer, Belgium

Elisangela Dellamora, Brazil

Jacques Descotes, France

George A. Diaz, USA

Amalie Dyda, Australia

Eric Dziuban, USA

Richard K. Ellerkmann, Germany

Thomas Engelhardt, UK

Paulo R.B. Evora, Brazil

Fabien G. Eyal, USA

Jay D. Fisher, USA

Julia Freeman, USA

Lawrence K. Fung, USA

Giovanni Gabutti, Italy

Aristea S. Galanopoulou, USA

Jose Garza, USA

Stefan Gebhardt, Germany

Dominique Gendrel, France

Andrew R. Gennery, UK

Jennifer Girotto, USA

Ronald Goldberg, USA

Jennifer L. Goldman, USA

Kenneth R. Goldschneider, USA

Andrew L. Gray, South Africa

Judith Guzman-Cottrill, USA

Benjamin Handen, USA

Henrik Hasle, Denmark

Seth Housman, USA

David Hyun, USA

David Isaacs, Australia

Vanessa Jordan, New Zealand

Robert R.M. Kennedy, USA

James Kidd, USA

Byoung-Ju Kim, Republic of Korea

Yoichiro Kino, Japan

Chad Knoderer, USA

Mukadder U. Kocak, Turkey

Chrysovalantis Korfitis, Greece

Pekka Lahdenne, Finland

Claudia Lanvers-Kaminsky, Germany

J. Bradley Layton, USA

Jacky W.Y. Lee, Hong Kong

Neal LeLeiko, USA

Piet L.J.M. Leroy, the Netherlands

Deborah M. Levy, USA

Byung Gun Lim, Republic of Korea

Jeffrey Lu, USA

David Mandelbaum, USA

Peter Manu, USA

Holly D. Maples, USA

Pierluigi Marzuillo, Italy

Norikazu Matsunaga, Japan

Natalia Maximova, Italy

Ann W. McMahon, USA

Ewan McNicol, USA

Maurizio Miano, Italy

Jorge Morales, Chile

Neil N.S. Morton, UK

Sergey Motov, USA

Wassim Nasreddine, Lebanon

Marcella Nebbioso, Italy

Kristen R. Nichols, USA

Anna Nolan, USA

Tony A.J. Nunn, UK

Ann-Christine Nyquist, USA

Joao B. Oliveira, Brazil

Christophe Orssaud, France

Nathan L. Pace, USA

David Pace, Malta

We would like to take this opportunity to thank retiring Honorary Editorial Board members Professors Dominique Gendrel, David Knoppert and Christopher Kratochvil, and to welcome new members Professors Saskia de Wildt, Emmanuel Roilides and Catherine Sherwin and thank them for their willingness to contribute to the success of Pediatric Drugs. Indeed, we gratefully acknowledge all of the members of the journal’s Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes:

Marina Aloi, Italy

Stan L. Block, USA

Andrew Bush, UK

Rolando Cimaz, Italy

Saskia de Wildt, the Netherlands

Seymour Diamond, USA

Brian Eley, South Africa

Susanna Esposito, Italy

Robert L. Findling, USA

Dominic Fitzherald, Australia

David A. Gremse, USA

Andreas H. Groll, Germany

Scott A. Halperin, USA

Julian Hamilton-Shield, UK

Gregory L. Holmes, USA

Giorgio Ivani, Italy

Gregory L. Kearns, USA

Gideon Koren, Israel

Desiree Kunac, New Zealand

Zvi Laron, Israel

Stephen Lowis, UK

Stuart MacLeod, Canada

Dinesh K. Mehta, UK

Kathleen A. Neville, USA

Antje Neubert, Germany

Michael E. Pichichero, USA

Emmanuel Roilides, Greece

Catherine M. Sherwin, USA

Robert Sidbury, USA,

William M. Splinter, Canada

Jeffrey A. Towbin, USA

John van den Anker, USA

Hervé Walti, France

Ian C. Wong, UK

Finally, Pediatric Drugs is dedicated to improving the effective and safe use of drugs, including vaccines, in pediatrics, and the Aims and Scope of the journal have been amended slightly to emphasize this.

We hope that you have found the articles published throughout 2016 to be both interesting and informative. We have appreciated the high quality of content contributed to the journal this year and we look forward to keeping you up to date with topical issues in the pediatric pharmacotherapy field in 2017.

With best wishes from the staff at of Pediatric Drugs and all at Adis Publications.